SERVICES / FINANCIAL NAVIGATION CFO ADVISORY FOR LIFE SCIENCES

CFO Advisory for Life Sciences

CFO-level leadership for runway, FP&A, board reporting, and decision support—built for life sciences growth companies. Strategic finance leadership without the full-time overhead—built for growth-stage life sciences.

Who This Is For

CFO, VP Finance, Controller

Pharma / biotech, pre-commercial through mid-market to global scale.

CEO, Earlier-Stage Biotech

Needing CFO-level leadership without a full-time hire.

Revenue Accounting, Compliance & Internal Audit

Stakeholders who need finance leadership aligned to their function.

Challenges We Solve

"Our GTN Is a Black Box"

Volatility, forecast misses, surprise true-ups.

Slow, Stressful Close

Accruals aren't defensible.

Cross-Functional Friction

Finance vs. Access vs. Commercial.

HOW I HELP

How I Help Life Sciences Leaders Win in the Margins

GTN Strategy & Methodology

Design the approach, assumptions, and governance.

Forecasting & Accruals

Improve accuracy, granularity, and close cadence.

Reconciliation & Controls

Audit-ready documentation, true-ups, and reviews.

Market Navigation Finance

Pricing / access tradeoffs, contracting implications.

Systems Architecture

Model N / SAP / EPM integration and automation roadmap.

CFO Advisory Leadership

Runway, FP&A, board reporting, decision support.

Engagement Framework

STEP 01
DIAGNOSE
STEP 02
DESIGN
STEP 03
IMPLEMENT
STEP 04
GOVERN
Patrick's expertise in Hyperion Planning and process reengineering was transformative. He didn't just manage our finances; he built a navigation system that allowed us to scale with confidence.
CHIEF FINANCIAL OFFICER

Counterplay Games

Frequently Asked Questions

What's the difference between this and hiring a full-time CFO or GTN lead?

You get senior operator-level leadership and a proven playbook without the fixed cost or time-to-hire—then we build what you need to sustain internally.

Do you work with pre-commercial biotech?

Yes—especially for launch readiness: reserves methodology, channel strategy implications, and the operating model needed for the first 12 months post-launch.

What happens in the first consultation?

You'll leave with a clear definition of the problem, where risk is concentrated, and the fastest path to a defensible, forecastable GTN model—plus a recommended engagement option.

Ready to Make GTN a Strategic Advantage?

Strategic finance leadership without the full-time overhead—built for growth-stage life sciences.

Schedule a Consultation